These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 18501909

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
    Holland EJ, Lane SS, Kim T, Raizman M, Dunn S.
    Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
    [Abstract] [Full Text] [Related]

  • 6. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery.
    Ong-Tone L.
    J Cataract Refract Surg; 2008 May; 34(5):819-22. PubMed ID: 18471639
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Sinus tissue concentration of moxifloxacin after a single oral dose.
    Dinis PB, Monteiro MC, Martins ML, Silva N, Morais JG.
    Ann Otol Rhinol Laryngol; 2004 Feb; 113(2):142-6. PubMed ID: 14994771
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort.
    Majcher-Peszynska J, Sass M, Schipper S, Czaika V, Gussmann A, Lobmann R, Mundkowski RG, Luebbert C, Kujath P, Ruf BR, Koch H, Schareck W, Klar E, Drewelow B, Moxifloxacin-DFI Study Group.
    Eur J Clin Pharmacol; 2011 Feb; 67(2):135-42. PubMed ID: 20871984
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic variables of moxifloxacin in healthy male camels following intravenous and intramuscular administration.
    Abd El-Aty AM, Goudah A, Shah SS, Shin HC, Shimoda M, Shim JH.
    J Vet Pharmacol Ther; 2007 Dec; 30(6):586-91. PubMed ID: 17991229
    [No Abstract] [Full Text] [Related]

  • 14. Moxifloxacin: new indication. Do not use in gynaecological infections or other conditions.
    Prescrire Int; 2009 Oct; 18(103):207. PubMed ID: 19882788
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis.
    Stass H, Rink AD, Delesen H, Kubitza D, Vestweber KH.
    J Antimicrob Chemother; 2006 Sep; 58(3):693-6. PubMed ID: 16895940
    [Abstract] [Full Text] [Related]

  • 16. Moxifloxacin penetration in bronchial secretions of mechanically ventilated patients with pneumonia.
    Leone M, Albanèse J, Sampol-Manos E, Simon N, Lacarelle B, Bruguerolle B, Martin C.
    Antimicrob Agents Chemother; 2004 Feb; 48(2):638-40. PubMed ID: 14742226
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
    Vasavada AR, Gajjar D, Raj SM, Vasavada V, Vasavada V.
    J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.